Given the elevated circulating renin level in Eln+/− mice and about half of WS patients, it would be of interest to investigate the impact of ROS-limitating agents like apocynin and tempol on the contraction of the ascending aorta in response to angiotensin II. Here, REN is linked to Werner syndrome.